|
TENX | Tenax Therapeutics, Inc. |
|
|
TENX | Tenax Therapeutics, Inc. |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 0.52 |
| Leverage | 6.42% |
| Market Cap | $ 183.9m |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -65.5m |
| Margin | -69660.27% |
Tenax Therapeutics, Inc., a specialty pharmaceutical company, is dedicated to identifying, developing, and marketing products for cardiovascular and pulmonary disease in the United States and Canada. The company is headquartered in Morrisville, North Carolina.